|
 |
Long-Term Follow-Up of Participants With Heart Failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
LB Piller, S Baraniuk, LM Simpson, WC Cushman... - Circulation, 2011 - Am Heart Assoc Abstract BackgroundIn the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), a randomized, double-blind, practice-based, active-control, comparative effectiveness trial in high-risk hypertensive participants, risk of new-onset ...
From the University of Texas School of Public Health, Houston, TX (L.B.P., S.B., L.M.S., C.E.F., B.R.D.); Memphis Veterans Affairs Medical Center, Memphis, TN (W.C.C.); San Francisco Veterans Affairs Medical Center and University of California, San Francisco, CA (B.M.M.); National Heart, Lung, and Blood Institute, Bethesda, MD (P.T.E.); University of Alabama at Birmingham, Birmingham, AL (S.O.); University of Illinois College of Medicine, Peoria, IL (J.F.G.); Marshfield Clinic Research Foundation, Marshfield, WI (R.A.D.); Mercer University School of Medicine, Macon, GA (D.C.P.); Howard University College of Medicine, Washington, DC (T.M.R.); Nassau University Medical Center, East Meadow, NY (A.B.C.); Fargo Veterans Affairs Medical Center, Fargo, ND (S.Z.J.); Wake Forest University School of Medicine, Winston-Salem, NC (C.D.F.); Veterans Affairs Medical Center and Wright State University, Dayton, OH (M.G.S.); University of Oklahoma Health Sciences Center and Department of Veterans Affairs Medical Center, Oklahoma City, OK (U.T.); University of Washington, Seattle, WA (J.L.P.); for the ALLHAT Collaborative Research Group (see reference 16).
More Details:
Long-Term Follow-Up of Participants With Heart Failure in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) |
|
|
